Experimental drug may extend therapeutic window for stroke

Clinical safety trials in humans to start this summer

2012-07-18

(Press-News.org) LOS ANGELES — A team led by a physician-scientist at the University of Southern California (USC) has created an experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally approved clot-busting therapy.

Clinical trials to test the safety of the drug in people are expected to start later this summer.

Stroke, which occurs when blood flow to a part of the brain stops, is the No. 4 cause of death and the leading cause of adult disability in the United States. According to the American Stroke Association, the Food and Drug Administration-approved tPA (tissue plasminogen activator) is the best treatment for stroke caused by a blocked artery, but to be effective, it must be administered within three hours after symptoms start. If given outside that three-hour window, tPA has shown serious side effects in animal and human brains, including bleeding and breakdown of the brain's protective barrier.

Generally, according to the American Stroke Association, only 3 to 5 percent of those who suffer a stroke reach the hospital in time to be considered for tPA treatment.

"What tPA does best is to break down clots in the blood vessel and restore blood flow, but it is a powerful enzyme," said Berislav V. Zlokovic, M.D., Ph.D., director of the Zilkha Neurogenetic Institute at the Keck School of Medicine of USC and the study's lead investigator. "After three hours, tPA also damages the blood vessel and causes intracerebral bleeding. We have developed something that not only counteracts the bleeding but also reduces brain damage and significantly improves behavior after stroke. I feel very strongly that this approach will extend the therapeutic window for tPA."

Zlokovic is the scientific founder of ZZ Biotech, a Houston-based biotechnology company he co-founded with USC benefactor Selim Zilkha to develop biological treatments for stroke and other neurological ailments. The company's 3K3A-APC is a genetically engineered variant of the naturally occurring activated protein C (APC), which plays a role in the regulation of blood clotting and inflammation. APC has cell-protecting, anti-inflammatory and anti-coagulant properties; 3K3A-APC has reduced anti-coagulant ability, which minimizes the risk of bleeding induced by normal APC. The protective effect of 3K3A-APC on the lining of blood vessels in the brain further helps prevent bleeding caused by tPA.

In collaboration with the University of Rochester Medical Center, Henry Ford Health Sciences Center, University of Arizona College of Medicine and The Scripps Research Institute, Zlokovic and his team gave tPA — alone and in combination with 3K3A-APC — to mice and rats four hours after stroke. They also gave 3K3A-APC for three consecutive days after stroke. They measured the amount of brain damage, bleeding and motor ability of the rodents up to seven days afterward.

The researchers found that, under those conditions, tPA therapy alone caused bleeding in the brain and did not reduce brain damage or improve motor ability when compared to the control. The combination of tPA and 3K3A-APC, however, reduced brain damage by more than half, eliminated tPA-induced bleeding and significantly improved motor ability.

"Dr. Zlokovic's study really demonstrates the promise of the drug and we are eager to show the same results in human clinical trials," said Kent Pryor, Ph.D., M.B.A., ZZ Biotech's chief operating officer.

Previous research suggests that the experimental drug may also protect against other neurological maladies such as amyotrophic lateral sclerosis and traumatic brain injury as a standalone therapy.

"We are encouraged by these results," said Joe Romano, CEO and president of ZZ Biotech. "In terms of improving treatment for stroke and other neurological diseases, this could be really exciting."

### The research was supported by ZZ Biotech and grants from the National Heart, Lung and Blood Institute of the National Institutes of Health (R01-HL063290-14, R01-HL052246-18).

Results of the study, "An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents," are available online in the journal Stroke, published by the American Heart Association.

ELSE PRESS RELEASES FROM THIS DATE:

NASA's TRMM satellite eyeing Tropical Storm Khanun's rainfall

2012-07-18

The Tropical Rainfall Measuring Mission (TRMM) is keeping an eye on the rainfall being generated by Tropical Storm Khanun as it moves past Kadena Air Base, Okinawa, Japan. The TRMM satellite had an excellent daytime look at Tropical Storm Khanun near Okinawa in the northwestern Pacific Ocean on July 17, 2012 at 0439 UTC (12:39 a.m. EDT/1:39 p.m. Japan). Khanun had estimated wind speeds of over 40 knots (~46 mph) at the time TRMM passed overhead. The storm was compact but well organized and shows possible eye wall formation. The bulk of the strongest precipitation was ...

NASA watching Tropical Storm Fabio head to southern California

2012-07-18

Southern California's coast is already feeling rough surf from Tropical Storm Fabio, and as the storm draws closer it is expected to bring scattered showers and thunderstorms as well. NASA's Aqua satellite peered into Fabio's clouds to see what power lurks under them, and saw only a small area of heavy rainfall remaining and the cooler waters that Fabio is now moving through. When NASA's Aqua satellite passed over Tropical Storm Fabio on July 16 at 2135 UTC (5:35 p.m. EDT), the Atmospheric Infrared Sounder (AIRS) instrument captured temperatures of cloud tops and the ...

The electric atmosphere: Plasma is next NASA science target

2012-07-18

Our day-to-day lives exist in what physicists would call an electrically neutral environment. Desks, books, chairs and bodies don't generally carry electricity and they don't stick to magnets. But life on Earth is substantially different from, well, almost everywhere else. Beyond Earth's protective atmosphere and extending all the way through interplanetary space, electrified particles dominate the scene. Indeed, 99% of the universe is made of this electrified gas, known as plasma. Two giant donuts of this plasma surround Earth, trapped within a region known as the Van ...

ICAP study uses novel incentive to encourage HIV patient care and treatment

2012-07-18

In a new study by ICAP at Columbia's Mailman School of Public Health, researchers are assessing a novel approach to encourage newly diagnosed HIV positive people to seek care and adhere to HIV treatment. The unique study in the HIV Prevention Trials Network (HPTN) gives people who test HIV positive a coupon for a gift card to claim after they complete clinic visits and laboratory tests. Patients who adhere to HIV treatment regularly can decrease the amount of HIV in their blood, leading to viral suppression. Study participants who achieve viral suppression also receive ...

Doctors and rheumatoid arthritis patients differ on perception of disease activity

2012-07-18

Researchers from Austria have determined that patients with rheumatoid arthritis (RA) and their doctors differ on perception of RA disease activity. The study now available in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR) and published by Wiley, reports that RA patients cite joint pain as the reason for their perception of a change in their disease activity. Rheumatologists, however, stressed joint swelling as the major determinant for their perception of change in RA disease activity. RA is a systemic rheumatic disease that causes inflammation, ...

Sugar-sweetened drinks are not replacing milk in kid's diets

2012-07-18

Philadelphia, PA, July 18, 2012 – National data indicate that milk consumption has declined among children while consumption of sweetened beverages of low nutritional quality has more than doubled. Although this suggests that sugar-sweetened beverages may have replaced more nutritious drinks in children's diets, a new study suggests that in fact changes in children's milk consumption are not significantly related to changes in their consumption of sodas and flavored fruit drinks over time. The results are published online today in the Journal of the Academy of Nutrition ...

Lowering the national ozone standard would significantly reduce mortality and morbidity

2012-07-18

Establishing a more stringent ozone standard in the U.S. would significantly reduce ozone-related premature mortality and morbidity, according to a new study published online July 18 in the journal Environmental Health Perspectives. "Abundant evidence links exposure to ozone with adverse health effects, including impaired pulmonary function, asthma exacerbations, increased hospital and emergency room visits, and increased mortality, yet the current National Ambient Air Quality Standard of 75ppb is often exceeded," said lead author Jesse Berman, a PhD candidate at Johns ...

Developing policy on moving threatened species called 'a grand challenge for conservation'

2012-07-18

Managed relocation—the act of purposely relocating a threatened species, population, or genotype to an area that is foreign to its natural history—is a controversial response to the threat of extinction resulting from climate change. An article in the August 2012 issue of BioScience by Mark W. Schwartz and his colleagues reports on the findings of the Managed Relocation Working Group, an interdisciplinary group of scientists, researchers, and policymakers whose goals were to examine the conditions that might justify the use of managed relocation and to assess the research ...

Hepatitis C may increase deaths from both liver-related and other diseases

2012-07-18

[EMBARGOED FOR JULY 18, 2012] In a long-term study of people infected with the hepatitis C virus (HCV), researchers found increased deaths from both liver-related and non-liver related diseases in patients with active infections who had not cleared their infection. The study, published in the Journal of Infectious Diseases and available online, found increased mortality in patients with chronic HCV infection—that is, with detectable levels of HCV genetic material, or RNA, in their blood—suggesting that chronic HCV infections, even in people who have no symptoms, can lead ...

New media, old messages: Obama and family are target of 'blackface' racism on Facebook

2012-07-18

Fans of Facebook hate groups, while using new media to target President Obama and his family, are relying heavily on old stereotypes of blacks as animalist, evil or shiftless — including depictions of the President as a chimp or sporting a bandana and a mouth full of gold teeth, according to a Baylor University study. More than 20 Facebook groups/pages were analyzed, using the keywords, "hate," "Barack Obama," and "Michelle Obama" to pinpoint them, in a study by Mia Moody, Ph.D., assistant professor of journalism, public relations and new media in Baylor's College of Arts ...

Experimental drug may extend therapeutic window for stroke

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: